Leiden University Scholarly Publications

Persistent URL of this record https://hdl.handle.net/1887/86867

Documents

Beta release

Statistics of Adjuvant dose-dense doxorubicin-cyclophosphamide versus docetaxel-doxorubicin-cyclophosphamide for high-risk breast cancer: First results of the randomised MATADOR trial (BOOG 2004-04)
Statistics for this year
PeriodVisitsDownloads
202499
Statistics for the last 3 months
PeriodVisitsDownloads
2024-0622
2024-0711
2024-0811